Le Lézard
Classified in: Science and technology
Subjects: PDT, TDS

Rainbow Robotics unveils RB-Y1, Korea's first bimanual mobile manipulator


- In March, "2024 Smart Factory Automation Industry Exhibition (SF+AW 2024)" was first released to the public

- Posting various performance videos of bimanual mobile manipulator in the form of humanoids on YouTube channels

DAEJEON, South Korea, April 5, 2024 /PRNewswire/ -- Rainbow Robotics, the robot platform company, announced that it has released detailed specifications of RB-Y1, the first bimanual mobile manipulator developed in Korea, and posted various performance videos on the Rainbow Robotics YouTube channel.

Korea's first bimanual mobile manipulator RB-Y1 spec

RB-Y1 is a form of mounting a humanoid-type double-arm robot on a wheel-type high-speed mobile base to enable work in various environments. In order to naturally perform various and complex tasks, both arms are equipped with 7 degrees of freedom and consist of a single leg with a 6-axis degree of freedom that can move the body. In particular, it is possible to move more than 50 cm vertically, making it possible to perform tasks at various heights.

The driving operation speed is 2.5m/s, and various types of high-speed turning and sudden acceleration are possible using 20-axis full-body control. In addition, the center of gravity can be safely controlled by using a single leg with 6 degrees of freedom while driving.

RB-Y1 has the level of reliability and performance of industrial robots because it was developed using the core components used in cooperative robots and AMR. Since it has 22 axes excluding wheels, it is complex to generate motion for this robot. However, it is possible to teach the robot (slave) by linking the data arm (master) to train them. It also has a function to prevent self-collision when the user teaches by setting the self-collision area of both arms. Additionally, a simulation environment for learning has been established to utilize AI.

An official from Rainbow Robotics said, "These days, when Generative AI such as ChatGPT and Figure is a hot topic in the robot industry, we have developed a bimanual mobile manipulator in line with the AI era," adding, "We hope that the platform will overcome the limitations of existing industrial robots and be used in many industrial sites."

Reference) RB-Y1 YouTube video link
Dynamic driving - https://youtu.be/Y3538CJb6TY?si=ThIsr4TAWfRWSq3F
Pouring water - https://youtu.be/JX8_Z64zo_k?si=PcCGLF3q28KA_IX5
Cup stacking - https://youtu.be/MMAiJi-kodg?si=_sKC8V8hMo3WehQS

Photo - https://mma.prnewswire.com/media/2379441/bimanual_mobile_manipulator_RB_Y1.jpg


These press releases may also interest you

at 16:40
FalconStor Software, Inc. , a trusted data protection leader modernizing disaster recovery and backup for the hybrid cloud world, today announced financial results for its first quarter of 2024, which ended on March 31, 2024. "In Q1, we continued...

at 16:40
Rimini Street, Inc. , a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced that TrustRadius has...

at 16:40
Johnson & Johnson will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman,...

at 16:40
Salesforce , the global leader in CRM, today announced that its first quarter fiscal year 2025 results will be released on Wednesday, May 29, 2024, after the close of the market. The company will host a conference call at 2:00 p.m. (PT) / 5:00 p.m....

at 16:37
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that it has set a record date of May 17, 2024 (the "Record Date") for the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary, Inhibrx...

at 16:35
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the quarter ended March...



News published on and distributed by: